LAURA FELLER: Open Payments
NPI 1972944924 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 36 payments from 18 companies in 2025. Trend: 2023 $2,525 · 2024 $1,070 · 2025 $866
Food & beverage: $791Education: $75
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 6 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Janssen Biotech, Inc. | 1 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $61 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| PFIZER INC. | 2 | $33 |
| GENZYME CORPORATION | 1 | $32 |
| JAZZ PHARMACEUTICALS INC. | 1 | $31 |
Products named: XT CDX, OPDIVO, KISQALI, DARZALEX, ENHERTU, KEYTRUDA, SARCLISA, ZEPZELCA.
Industry payments across IN — which companies pay providers there.
